Clinical Trial Update: Effects of Fractional CO2 Laser Treatment on Vaginal Symptoms and Sexual Dysfunction in Women With Systemic Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial investigating fractional CO2 laser treatment for vaginal symptoms and sexual dysfunction in women with systemic sclerosis has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sexual Function Disturbances
• Systemic Sclerosis
• Vulvovaginal Signs and Symptoms

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Systemic Sclerosis, Vulvovaginal Signs and Symptoms | Phase 2, Phase 3 | Status: COMPLETED